RIVO Health 4-in-1 VAST Reviewed as a Four-Ingredient Sublingual Prescription Option for Men Seeking Online ED Care
STAFFORD, Texas — July 6, 2026 — RIVO Health ’s 4-in-1 VAST is being presented as a compounded prescription option for men exploring online erectile dysfunction (ED) care. The four-ingredient sublingual formulation combines Vardenafil, Sildenafil, Tadalafil, and Apomorphine and is available through a telehealth consultation and licensed clinician approval process.
According to information provided by RIVO Health , 4-in-1 VAST contains Vardenafil 7.5 mg, Sildenafil 40 mg, Tadalafil 4 mg, and Apomorphine 2 mg. The liquid formulation is administered under the tongue rather than swallowed.4-in-1 VAST is a compounded prescription medication available only after consultation and approval by a licensed healthcare provider
RIVO Health states that the sublingual delivery is designed to provide an onset of approximately 10 minutes, while the inclusion of Tadalafil is associated with an advertised active window of up to 36 hours. These statements represent brand-provided claims and should not be interpreted as independently established clinical outcomes for the finished compounded formulation.See if you qualify for RIVO Health 4-in-1 VAST – official intake page
Four-Ingredient Formulation
The 4-in-1 VAST formula combines three PDE5 inhibitors with Apomorphine, which belongs to a different class of medication.
Vardenafil is included at 7.5 mg and is described by RIVO Health as part of the formula intended to support a faster onset. Sildenafil, at 40 mg, is another PDE5 inhibitor commonly used in the treatment of ED. Tadalafil, at 4 mg, is associated with the formulation’s longer-duration positioning.
The fourth ingredient, Apomorphine at 2 mg, is a dopamine agonist that acts through the central nervous system rather than directly through the same pathway as PDE5 inhibitors. RIVO Health notes that Apomorphine is included as part of its approach to the broader physical and psychological aspects associated with sexual function.
Confirm which provider network reviews your specific application
Because Apomorphine is not FDA-approved specifically for the treatment of ED in the United States, consumers are encouraged to discuss its use, potential risks, interactions, and suitability with the prescribing healthcare professional.
Telehealth Consultation and Prescription Process
4-in-1 VAST is not an over-the-counter product. According to RIVO Health , consumers begin the process by completing an online health questionnaire covering medical history, current medications, and other relevant health information.
An independent licensed healthcare provider reviews the submitted information and determines whether treatment is clinically appropriate. Approval is not guaranteed.
If a prescription is approved, RIVO Health states that a third-party compounding pharmacy prepares and ships the medication.
The company distinguishes between the RIVO Health platform, the independent prescribing clinicians, and the pharmacy responsible for fulfillment. RIVO Health ‘s published materials state that Cured Med, LLC operates the platform but does not itself prescribe medication or provide healthcare services.
Confirm which provider network reviews your specific application
Consumers Encouraged to Review Product Claims Carefully
RIVO Health ‘s product materials use claims including “10X Faster,” “10-Minute Onset,” “6X Longer,” and “36-Hour Window.” The company associates these statements with the formulation’s sublingual delivery and the known duration profile of Tadalafil.
However, consumers should distinguish brand marketing statements from independently verified clinical evidence. In particular, claims concerning comparative performance against established ED medications should not be interpreted as evidence of clinical superiority without appropriate comparative studies.
The advertised 36-hour window also does not mean that an erection remains continuously present for 36 hours. It refers to the period during which medication may remain active, with individual responses varying according to factors such as metabolism, health status, and other medications.See current pricing before your billing cycle starts
What Consumers Should Confirm Before Treatment
Before beginning a compounded prescription treatment, consumers may wish to discuss several questions with their healthcare provider, including whether the formulation is appropriate for their medical history, whether their existing medications could interact with any of the ingredients, and why the four ingredients are being combined.
Consumers should also ask about potential side effects, warning signs, the pharmacy responsible for preparation, subscription and cancellation terms, and what steps to take if the treatment does not produce the expected results.
Compounded medications are not evaluated by the FDA in the same manner as FDA-approved finished drug products. Consumers should therefore make treatment decisions in consultation with an appropriately licensed healthcare professional.
About RIVO Health 4-in-1 VAST
RIVO Health 4-in-1 VAST is a compounded prescription ED formulation marketed through RIVO Health ‘s telehealth platform. The product combines Vardenafil, Sildenafil, Tadalafil, and Apomorphine in a sublingual liquid formulation.
Treatment is available only following medical consultation and approval by a licensed healthcare provider when clinically appropriate.
Official Website: RIVO Health
Product: 4-in-1 VAST
Category: Compounded prescription ED treatment
Availability: Requires licensed healthcare provider consultation and approval
Media Contact:
Email: [email protected]
Company: Cured Med, LLC
Country: USA
Person: RIVO Health Support
Website.Website: https://ed.rivohealth.co/4-in-1-vast